Publikationen im NUM
Hier finden Sie eine Liste der Publikationen, die im Zusammenhang mit dem Netzwerk Universitätsmedizin in der ersten und zweiten Förderphase entstanden sind.
M. Weber,
M. Plew,
C. Neumann Weber and
et al,
"Perceived importance of pandemic interventions for attending cultural events – Findings from Germany",
BMC Public Health,
2021.
| DOI: | 10.21203/rs.3.rs-776085/v1 |
M. Kahn,
L. Schuierer,
C. Bartenschlager and
et al,
"Performance of antigen testing for diagnosis of COVID-19: a direct comparison of a lateral flow device to nucleic acid amplification based tests",
BMC Infect Dis,
vol. 21,
no. 1,
2021.
| DOI: | 10.1186/s12879-021-06524-7 |
R. A. Lee,
J. C. Herigon,
A. Benedetti and
et al,
"Performance of saliva, oropharyngeal swabs, and nasal swabs for SARS-CoV-2 molecular detection: A systematic review and meta-analysis",
J Clin Microbiol,
vol. 59,
no. 5,
2021.
| DOI: | 10.1128/JCM.02881-20 |
| Datei: | https://doi.org/10.1128/JCM.02881-20 |
N. Kreuzberger and
et al,
"Persistence of immunoglobulin G after natural infection with SARS-CoV-2",
Cochrane Database of Systematic Reviews,
2021.
| DOI: | 10.1002/14651858.CD014946 |
L. Michalick,
S. Weidenfeld,
B. Grimmer,
D. Fatykhova,
P. D. Solymosi,
F. Behrens,
M. Dohmen,
M. Brack,
S. Schulz,
E. Thomasch,
S. Simmons,
H. Müller-Redetzky,
N. Suttorp,
F. Kurth,
J. Neudecker,
M. Toennies,
T. T. Bauer,
S. Eggeling,
V. M. Corman,
A. C. Hocke,
M. Witzenrath,
S. Hippenstiel and
W. M. Kuebler,
"Plasma mediators in patients with severe COVID-19 cause lung endothelial barrier failure",
Eur Respir J,
vol. 57,
no. 3,
pp. 2002384,
2021.
| DOI: | 10.1183/13993003.02384-2020 |
L. Michalick,
S. Weidenfeld,
B. Grimmer,
D. Fatykhova,
P. Solymosi,
F. Behrens,
M. Dohmen,
M. Brack,
S. Schulz,
E. Thomasch and
D. Stahl,
"Plasma mediators in patients with severe COVID-19 cause lung endothelial barrier failure",
Eur Respir J,
vol. 57,
no. 3,
2021.
| DOI: | 10.1183/13993003.02384-2020 |
A. Joachim,
F. Dewald,
I. Suárez and
et al,
"Pooled RT-qPCR testing for SARS-CoV-2 surveillance in schools: A cluster randomised trial",
EClinicalMedicine,
vol. 39,
2021.
| DOI: | 10.1016/j.eclinm.2021.101082 |
M. Roessler,
F. Tesch,
M. Batram,
J. Jacob,
F. Loser,
O. Weidinger,
D. Wende,
A. Vivirito,
N. Toepfner,
M. Seifert,
O. Nagel,
C. König,
R. Jucknewitz,
J. P. Armann,
R. Berner,
M. Treskova-Schwarzbach,
D. Hertle,
S. Scholz,
S. Stern,
J. Schmitt and
D. Stahl,
"Post COVID-19 in children, adolescents, and adults: Results of a matched cohort study including more than 150,000 individuals with COVID-19",
2021.
| DOI: | 10.1101/2021.10.21.21265133 |
M. Augustin and
et al,
"Post-COVID syndrome in non-hospitalised patients with COVID-19: a longitudinal prospective cohort study",
The Lancet Regional Health. Europe,
vol. 6,
pp. 100122,
2021.
| DOI: | 10.1016/j.lanepe.2021.100122 |
D. Niemeyer,
S. Schroeder and
K. Friedmann,
"Post-entry, spike-dependent replication advantage of B.1.1.7 and B.1.617.2 over B.1 SARS-CoV-2 in an ACE2-deficient human lung cell line",
BioRxiv,
2021.
| DOI: | 10.1101/2021.10.20.465121 |
D. Niemeyer,
S. Schroeder,
K. Friedmann,
F. Weege,
J. Trimpert,
A. Richter,
S. Stenzel,
J. Jansen,
J. Emanuel,
J. Kazmierski,
F. Pott,
L. M. Jeworowski,
R. Olmer,
M. Jaboreck,
B. Tenner,
J. Papies,
J. Heinze,
F. Walper,
M. L. Schmidt,
N. Heinemann,
E. Möncke-Buchner,
T. Veith,
M. Baumgardt,
K. Hoffmann,
M. Widera,
T. T. N. Thao,
A. Balázs,
J. Schulze,
C. Mache,
M. Morkel,
S. Ciesek,
L. G. Hanitsch,
M. A. Mall,
A. C. Hocke,
V. Thiel,
K. Osterrieder,
T. Wolff,
U. Martin,
V. M. Corman,
M. A. Müller,
C. Goffinet and
C. Drosten,
"Post-entry, spike-dependent replication advantage of B.1.1.7 and B.1.617.2 over B.1 SARS-CoV-2 in an ACE2-deficient human lung cell line",
2021.
| DOI: | 10.1101/2021.10.20.465121 |
D. Niemeyer,
S. Schroeder,
K. Friedmann,
F. Weege,
J. Trimpert and
e. a. Richter,
"Post-entry, spike-dependent replication advantage of B.1.1.7 and B.1.617.2 over B.1 SARS-CoV-2 in an ACE2-deficient human lung cell line",
bioRxiv,
2021.
| DOI: | 10.1101/2021.10.20.465121 |
F. Heinrich,
K. Meißner,
F. Langenwalder,
K. Püschel,
D. Nörz,
A. Hoffmann,
M. Lütgehetmann,
E. Bibiza-Freiwald,
S. Pfefferle and
A. Heinemann,
"Postmortem stability of SARS-CoV-2 in nasopharyngeal mucosa",
Emerg Infect Dis,
vol. 27,
no. 1,
pp. 329-331,
2021.
| DOI: | 10.3201/eid2701.203112 |
P. Boor,
P. Eichhorn,
A. Hartmann,
S. F. Lax,
B. Märkl,
T. Menter,
K. Skok,
J. Slotta-Huspenina,
S. Stillfried,
A. Tzankov and
G. Weirich,
"Praktische Aspekte von COVID-19-Obduktionen [Practical aspects of COVID-19 autopsies]",
Pathologe,
vol. 42,
no. 2,
pp. 197-207,
2021.
M. Casagrande,
A. Fitzek,
M. S. Spitzer,
K. Püschel,
M. Glatzel,
S. Krasemann,
D. Nörz,
M. Lütgehetmann,
S. Pfefferle and
M. Schultheiss,
"Presence of SARS-CoV-2 RNA in the cornea of viremic patients with COVID-19",
JAMA Ophthalmol,
2021.
| DOI: | 10.1001/jamaophthalmol.2020.6339 |
M. Oestreich,
D. Chen,
J. L. Schultze,
M. Fritz and
M. Becker,
"Privacy considerations for sharing genomics data",
EXCLI journal,
vol. 20,
pp. 1243–1260,
2021.
| DOI: | 10.17179/excli2021-4002 |
T. Weinberger,
J. Steffen,
A. Osterman and
et al,
"Prospective longitudinal serosurvey of healthcare workers in the first wave of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) pandemic in a quaternary care hospital in Munich, Germany",
Clin Infect Dis,
vol. 73,
no. 9,
2021.
| DOI: | 10.1093/cid/ciaa1935 |
A. Fitzek,
J. Schädler,
E. Dietz,
A. Ron,
M. Gerling,
A. Kammal,
L. Lohner,
C. Falck,
D. Möbius,
H. Goebels,
A. Gerberding,
A. Schröder,
J. Sperhake,
A. Klein,
D. Fröb,
H. Mushumba,
S. Wilmes,
I. Kniep,
F. Heinrich,
F. Langenwalder,
K. Meißner,
P. Lange,
A. Zapf,
K. Püschel,
A. Heinemann,
M. Glatzel,
J. Matschke,
M. Lütgehetmann,
S. Steurer,
C. Thorns,
C. Edler and
B. Ondruschka,
"Prospective postmortem evaluation of 735 consecutive SARS-CoV-2-associated death cases",
Sci Rep,
vol. 11,
no. 1,
pp. 19342,
Sep.
2021.
| DOI: | 10.1038/s41598-021-98499-3 |
D. Lapuente,
J. Fuchs,
J. Willar and
et al,
"Protective mucosal immunity against SARS-CoV-2 after heterologous systemic prime-mucosal boost immunization",
Nat Commun,
vol. 12,
no. 1,
2021.
| DOI: | 10.1038/s41467-021-27063-4 |
| Datei: | https://doi.org/10.1038/s41467-021-27063-4 |
M. Oberste,
L. M. Pusch,
R. Roth and
et al,
"Protocol of the Cologne Corona Surveillance (CoCoS) study: A prospective population-based cohort study",
BMC Public Health,
vol. 21,
no. 1,
2021.
| DOI: | 10.1186/s12889-021-11206-9 |
J. Schwartz and
D. Stahl,
"Psychische Belastung des Intensivpersonals: Kommunikationsseminare helfen",
Deutsches Ärzteblatt,
vol. 118,
no. 50,
2021.
N. Röthke,
D. Wollschläger,
A. M. Kunzler,
A. Rohde,
S. Molter,
M. Bodenstein,
A. Reif,
H. Walter,
K. Lieb and
O. Tüscher,
"Psychische Belastung, Resilienz und Absentismusneigung bei Gesundheitspersonal in Deutschland während der ersten COVID-19-Pandemiewelle im Frühjahr 2020",
Der Nervenarzt,
vol. 92,
no. 6,
pp. 579—590,
2021.
| DOI: | 10.1007/s00115-021-01132-x |
I. M. Veer,
A. Riepenhausen,
M. Zerban,
C. Wackerhagen,
L. M. C. Puhlmann,
H. Engen,
G. Köber,
S. A. Bögemann,
J. Weermeijer,
A. Uściłko,
N. Mor,
M. A. Marciniak,
A. D. Askelund,
S. Ayash,
G. Barsuola,
V. Bartkute-Norkuniene,
S. Battaglia,
Y. Bobko and
D. Stahl,
"Psycho-social factors associated with mental resilience in the Corona lockdown",
Translational Psychiatry,
vol. 11,
no. 1,
pp. 1—11,
2021.
| DOI: | 10.1038/s41398-020-01150-4 |
| Datei: | https://doi.org/10.1038/s41398-020-01150-4 |
E. Morawa,
C. Schug,
F. Geiser,
P. Beschoner,
L. Jerg-Bretzke,
K. Weidner,
N. Hiebel,
A. Borho and
Y. Erim,
"Psychosocial burden and working conditions during the COVID-19 pandemic in Germany: The VOICE survey among 3678 health care workers in hospitals",
Journal of Psychosomatic Research,
vol. 144,
pp. 110415,
2021.
| DOI: | 10.1016/j.jpsychores.2021.110415 |
L. Jerg-Bretzke,
M. Kempf,
M. N. Jarczok,
K. Weimer,
C. Hirning,
H. Gündel,
Y. Erim,
E. Morawa,
F. Geiser,
N. Hiebel,
K. Weidner and
P. Beschoner,
"Psychosocial Impact of the COVID-19 Pandemic on Healthcare Workers and Initial Areas of Action for Intervention and Prevention—The egePan/VOICE Study",
International Journal of Environmental Research and Public Health,
vol. 18,
no. 19,
pp. 10531,
2021.
| DOI: | 10.3390/ijerph181910531 |
G. Anton,
A. Kuehn-Steven,
M. K. Taucher,
I. Bernemann and
T. Illig,
"Quality management in times of COVID-19: Remote audits as tool to assess sample quality for NAPKON.",
European Biobank Week 2021,
2021.
A. Denzler,
M. L. Jacobs,
V. Witte and
et al,
"Rapid comparative evaluation of SARS-CoV-2 rapid point-of-care antigen tests",
MedRxiv,
2021.
| DOI: | 10.1101/2021.07.29.21261314 |
| Datei: | https://doi.org/10.1101/2021.07.29.21261314 |
S. Kluge,
J. J. Malin,
F. Fichtner,
O. J. Müller,
N. Skoetz and
C. Karagiannidis,
"Recommendations on the In-Hospital Treatment of Patients With COVID-19",
Dtsch Arztebl Int,
2021.
| DOI: | 10.3238/arztebl.m2021.0374 |
K. I. Wagner and
et al,
"Recruitment of highly cytotoxic CD8+ T cell receptors in mild SARS-CoV-2 infection",
Cell reports,
vol. 35,
pp. 110214,
2021.
| DOI: | 10.1016/j.celrep.2021.110214 |
S. Bauer,
S. Contreras,
J. Dehning,
M. Linden,
E. Iftekhar,
S. B. Mohr,
A. Olivera-Nappa and
V. Priesemann,
"Relaxing restrictions at the pace of vaccination increases freedom and guards against further COVID-19 waves",
PLOS Computational Biology,
vol. 17,
no. 9,
pp. e1009288,
2021.
| DOI: | 10.1371/journal.pcbi.1009288 |
D. Thole,
T. Ole Diesterhöft,
S. Vogel,
M. Greve,
E. Bauer,
S. Strathmann,
C. Elsner,
N. Kolbe and
D. Krefting,
"Relevant Aspects for Sustainable Open Source Pandemic Apps and Platform Deployment with Focus on Community Building",
Stud Health Technol Inform,
vol. 283,
pp. 186—193,
2021.
| DOI: | 10.3233/SHTI210580 |
K. Ansems,
F. Grundeis,
K. Dahms,
A. Mikolajewska,
V. Thieme,
V. Piechotta,
M. Metzendorf,
M. Stegemann,
C. Benstoem and
F. Fichtner,
"Remdesivir for the treatment of COVID‐19",
Cochrane Database of Systematic Reviews,
vol. 2021,
no. 8,
pp. CD014962,
2021.
| DOI: | 10.1002/14651858.CD014962 |
D. Wurzer,
P. Spielhagen,
A. Siegmann,
A. Gercekcioglu,
J. Gorgass,
S. Henze,
Y. Kolar,
F. Koneberg,
S. Kukkonen,
H. McGowan,
S. Schmid-Eisinger,
A. Steger,
M. Dommasch,
H. U. Haase,
A. Müller,
E. Martens,
B. Haller,
K. M. Huster and
G. Schmidt,
"Remote monitoring of COVID-19 positive high-risk patients in domestic isolation: A feasibility study",
PLOS ONE,
vol. 16,
no. 9,
pp. e0257095,
2021.
| DOI: | 10.1371/journal.pone.0257095 |
| Datei: | https://doi.org/10.1371/journal.pone.0257095 |
S. Graf,
L. Engelmann,
O. Wölfler and
D. Stahl,
"Reopening the Bavarian State Opera Safely: Hygiene Strategies and Incidence of COVID-19 in Artistic Staff During Theater Season 2020/2021",
Journal of Voice,
2021.
| DOI: | 10.1016/j.jvoice.2021.11.012 |
| Datei: | https://doi.org/10.1016/j.jvoice.2021.11.012 |
M. Salholz-Hillel,
P. Grabitz,
M. Pugh-Jones,
D. Strech and
N. J. DeVito,
"Results availability and timeliness of registered COVID-19 clinical trials: interim cross-sectional results from the DIRECCT study",
BMJ Open,
vol. 11,
no. 11,
pp. e053096,
2021.
| DOI: | 10.1136/bmjopen-2021-053096 |
F. Nordsiek,
E. Bodenschatz,
G. Bagheri and
et al,
"Risk assessment for airborne disease transmission by poly-pathogen aerosols",
PLOS ONE,
2021.
| DOI: | 10.1371/journal.pone.0248004 |
M. Wunsch,
D. Aschemeier,
E. Hegera and
et al,
"Safe and effective pool testing for SARS-CoV-2 detection",
J Clin Virol,
vol. 145,
2021.
| DOI: | 10.1016/j.jcv.2021.105018 |
S. Reis,
M. Popp,
B. Schmid,
M. Stegemann,
M. Metzendorf,
P. Kranke,
P. Meybohm and
S. Weibel,
"Safety and Efficacy of Intermediate- and Therapeutic-Dose Anticoagulation for Hospitalised Patients with COVID-19: A Systematic Review and Meta-Analysis",
J Clin Med,
vol. 11,
no. 1,
pp. 57,
2021.
| DOI: | 10.3390/jcm11010057 |
D. Hillus and
et al,
"Safety, reactogenicity, and immunogenicity of homologous and heterologous prime-boost immunisation with ChAdOx1 nCoV-19 and BNT162b2: a prospective cohort study",
The Lancet Respiratory Medicine,
2021.
| DOI: | 10.1016/S2213-2600(21)00357-X |
M. Möckel,
V. M. Corman,
M. S. Stegemann and
et al,
"SARS-CoV-2 antigen rapid immunoassay for diagnosis of COVID-19 in the emergency department",
Biomarker,
vol. 26,
no. 3,
2021.
| DOI: | 10.1080/1354750X.2021.1876769 |
S. Deinhardt-Emmer,
S. Bottcher,
C. Haring,
L. Giebeler,
A. Henke and
e. a. Zell,
"SARS-CoV-2 causes severe epithelial inflammation and barrier dysfunction",
J Virol,
2021.
D. Wendisch,
O. Dietrich,
T. Mari,
S. Stillfried,
I. Ibarra,
M. Mittermaier,
C. Mache,
R. Chua,
R. Knoll,
S. Timm and
D. Stahl,
"SARS-CoV-2 infection triggers profibrotic macrophage responses and lung fibrosis",
Cell,
vol. 184,
no. 26,
pp. 6243—6261.e27,
2021.
| DOI: | 10.1016/j.cell.2021.11.033 |
D. Wendisch,
O. Dietrich,
T. Mari,
S. Stillfried,
I. L. Ibarra and
e. a. Mittermaier,
"SARS-CoV-2 infection triggers profibrotic macrophage responses and lung fibrosis",
Cell,
vol. 184,
pp. 6243—6261.e6227,
2021.
| DOI: | 10.1016/j.cell.2021.11.033 |
D. Wendisch and
et al,
"SARS-CoV-2 infection triggers profibrotic macrophage responses and lung fibrosis",
Cell,
vol. 184,
pp. 6243-6261.e27,
2021.
| DOI: | 10.1016/j.cell.2021.11.033 |
D. Wendisch,
O. Dietrich,
T. Mari and
et al,
"SARS-CoV-2 infection triggers profibrotic macrophage responses and lung fibrosis",
Cell,
2021.
| DOI: | 10.1016/j.cell.2021.11.033 |
D. Wendisch,
O. Dietrich,
T. Mari,
S. Von Stillfried,
I. Ibarra,
M. Mittermaier,
C. Mache,
R. Chua,
R. Knoll,
S. Timm,
S. Brumhard,
T. Kramer,
R. Mothes,
R. Bülow,
J. Schulze,
S. Djudjaj,
F. Pott,
J. Kazmierski,
J. Radke,
S. Baßler,
B. Conrad,
M. Landthaler,
E. Wyler,
D. Horst,
S. Hippenstiel,
A. Hocke,
F. Heppner,
A. Uhrig,
C. V. García,
S. Herold,
S. Elezkurtaj,
C. Thibeault,
M. Witzenrath,
N. Suttorp,
C. Drosten,
C. Goffinet,
F. Kurth,
J. L. Schultze,
H. Radbruch,
M. Ochs,
R. Eils,
H. C. Müller-Redetzky,
A. E. Hauser,
C. Conrad,
T. Wolff,
P. Boor,
L. E. Sander,
H. Zauber,
A. Hiller,
A. Pascual-Reguant,
A. Leipold,
F. Erhard,
R. Geffers,
P. Pergantis,
A. Aschenbrenner,
B. Sawitzki,
C. Cochain,
M. Luecken,
F. Theis,
M. Selbach,
A. Saliba and
F. Machleidt,
"SARS-CoV-2 infection triggers profibrotic macrophage responses and lung fibrosis.",
Cell. 2021;184(26):6243-6261.e27.,
2021.
J. Jansen,
K. Reimer,
J. Nagai and
et al,
"SARS-CoV-2 infects the human kidney and drives fibrosis in kidney organoids",
Cell Stem Cell,
2021.
| DOI: | 10.1016/j.stem.2021.12.010 |
M. Hoffmann and
et al,
"SARS-CoV-2 mutations acquired in mink reduce antibody-mediated neutralization",
Cell Reports,
vol. 35,
pp. 109017,
2021.
| DOI: | 10.1016/j.celrep.2021.109017 |
J. J. Malin and
et al,
"SARS-CoV-2 neutralizing antibody treatment in COVID-19 patients with immunodeficiency due to B-cell non-Hodgkin lymphoma",
Blood advances,
2021.
| DOI: | 10.1182/bloodadvances.2021006655 |
T. Schwarz and
et al,
"SARS-CoV-2 Proteome-Wide Analysis Revealed Significant Epitope Signatures in COVID-19 Patients",
Frontiers in immunology,
vol. 12,
pp. 629185,
2021.
| DOI: | 10.3389/fimmu.2021.629185 |